Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Using deep learning for dermatologist-level detection of suspicious pigmented skin lesions from wide-field images
148
Zitationen
14
Autoren
2021
Jahr
Abstract
A reported 96,480 people were diagnosed with melanoma in the United States in 2019, leading to 7230 reported deaths. Early-stage identification of suspicious pigmented lesions (SPLs) in primary care settings can lead to improved melanoma prognosis and a possible 20-fold reduction in treatment cost. Despite this clinical and economic value, efficient tools for SPL detection are mostly absent. To bridge this gap, we developed an SPL analysis system for wide-field images using deep convolutional neural networks (DCNNs) and applied it to a 38,283 dermatological dataset collected from 133 patients and publicly available images. These images were obtained from a variety of consumer-grade cameras (15,244 nondermoscopy) and classified by three board-certified dermatologists. Our system achieved more than 90.3% sensitivity (95% confidence interval, 90 to 90.6) and 89.9% specificity (89.6 to 90.2%) in distinguishing SPLs from nonsuspicious lesions, skin, and complex backgrounds, avoiding the need for cumbersome individual lesion imaging. We also present a new method to extract intrapatient lesion saliency (ugly duckling criteria) on the basis of DCNN features from detected lesions. This saliency ranking was validated against three board-certified dermatologists using a set of 135 individual wide-field images from 68 dermatological patients not included in the DCNN training set, exhibiting 82.96% (67.88 to 88.26%) agreement with at least one of the top three lesions in the dermatological consensus ranking. This method could allow for rapid and accurate assessments of pigmented lesion suspiciousness within a primary care visit and could enable improved patient triaging, utilization of resources, and earlier treatment of melanoma.
Ähnliche Arbeiten
Dermatologist-level classification of skin cancer with deep neural networks
2017 · 13.525 Zit.
Tumor Angiogenesis: Therapeutic Implications
1971 · 10.115 Zit.
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
2011 · 7.678 Zit.
Pembrolizumab versus Ipilimumab in Advanced Melanoma
2015 · 5.811 Zit.
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
2017 · 5.365 Zit.
Autoren
Institutionen
- Harvard–MIT Division of Health Sciences and Technology(US)
- IIT@MIT(US)
- Massachusetts Institute of Technology(US)
- Cambridge Health Alliance(US)
- Beth Israel Deaconess Medical Center(US)
- Harvard University(US)
- Lemuel Shattuck Hospital(US)
- Tufts Medical Center(US)
- Wellesley College(US)
- Massachusetts General Hospital(US)
- Hospital General Universitario Gregorio Marañón(ES)
- Broad Institute(US)